Product information and disease descriptionPlace of product in therapyApproaches to treatment
Care management intervention strategies
12 evidence topics · 14 sources
Summary
- Procedure and monitoring analogs: the prescribing information for Kebilidi, a product administered by stereotactic neurosurgery, directs monitoring for procedure-related adverse events, including continuous cardiorespiratory monitoring during hospitalization, and the FDA review states that procedural complications can be mitigated by post-procedural monitoring. Aetna considers brain MRI for stereotactic planning and intraoperative navigation medically necessary for members being considered for Kebilidi.
- Long-term follow-up: FDA guidance recommends long-term follow-up of up to five years for AAV vectors, with a risk-based approach to duration for vectors capable of long term expression without integration, such as AAV.
- Multidisciplinary care: a multidisciplinary position paper recommends a multidisciplinary team, an individualised care and treatment plan for every patient and family, and a case manager or coordinator. The Huntington's Disease Society of America states that no one doctor or caregiver should manage all aspects of an HD case, and that the goals of treatment are to reduce the burden of symptoms, maximize function, and optimize quality of life. HDSA Centers of Excellence provide neurologists, psychiatrists, social workers, therapists, counselors, and other professionals.
- Advance care planning: one guideline describes advance care planning as essential, including discussion of alternative feeding methods, and another recommends documenting living wills and care directives early and social worker support for financial assistance. In one study, engaging in advance care planning did not cause untoward effects on health-related quality of life or suicidal thoughts and behavior (STB), whose lifetime prevalence in HD approaches 30%.
- Palliative care: a review included 38 of 333 articles and found a low level of evidence for most topics. One publication states that referral to palliative care should be strongly considered for patients with pain, anxiety, sleep disturbances, and difficulty coping with the diagnosis.
Post-procedural monitoring after Kebilidi administration: label and FDA review
Pre-procedure imaging in Aetna criteria for Kebilidi: stereotactic planning MRI
Long-term follow-up after AAV gene therapy: FDA guidance
EHDN multidisciplinary position paper: managed care network and case manager
“The multidisciplinary team should be composed of different professionals who work closely together and interact within the group. It is also important to establish an individualised care and treatment plan for every single case of a patient and family. A case manager or coordinator may facilitate the work of the multidisciplinary team.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This position paper reveals that there are key essential professional groups involved in the MDT who do not have an HD guideline available, like psychologists, social workers, nurses, case managers and general practitioners.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
HDSA physician's guide: team care and Centers of Excellence
HDSA Centers of Excellence: team composition
Advance care planning: EHDN guideline
Advance care planning and psychosocial support: German Neurological Society guideline
“Early in the disease process, it is recommended to document living wills and care directives” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Moreover, there should be support from a social worker to navigate the complex bureaucracy to apply for and obtain financial assistance and support for care needs.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Advance care planning: multicenter HDQLIFE study
Palliative care in advanced disease: scoping review
“Our search resulted in 333 articles, 38 of which were included.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Most literature was underpinned by a low level of evidence, except for the topics on social care (Level III-V), advance care planning (Level II-V) and end-of-life needs assessments (Level II-III).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote